Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

14.98 +2.63 (+21.30%)

Official Closing Price Updated: 4:10 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Why Ginkgo Bioworks Stock Is Falling After Hours ↗

May 16, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

May 13, 2022

Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 9.65% since its last report. The company recently reported that it has 81.30 million shares sold short,...

Via Benzinga

7 Growth Stocks to Buy on the Dip ↗

May 10, 2022

Although the wave of red ink in the major indices is intimidating, it also presents an intriguing opportunity for growth stocks to buy.

Via InvestorPlace

Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why. ↗

April 27, 2022

DNA stock is in the spotlight after Ark Invest reported purchasing more than 1.5 million shares this week. So, who else is betting big on Ginkgo?

Via InvestorPlace

7 Biggest Loser Stocks That Could Become Surprising Buys ↗

April 27, 2022

A huge pouring of red ink can sometimes lead to extraordinary gains, though you’ve got to be aware of the risks.

Via InvestorPlace

Why Is Ginkgo Bioworks (DNA) Stock Up Today? ↗

April 13, 2022

Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result.

Via InvestorPlace

Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations ↗

March 29, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported

Via Benzinga

Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock ↗

January 28, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.

Via Benzinga

28 Biggest Movers From Yesterday ↗

April 14, 2022

Gainers HighPeak Energy, Inc. (NASDAQ: HPK) shares gained 31.76% to close at $28.83 on Wednesday, after CNBC’s Jim Cramer said the mid-cap company is an aggressive play on...

Via Benzinga

NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc. ↗

April 13, 2022

San Diego, CA -- (SBWIRE) -- 04/13/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Ginkgo Bioworks Holdings, Inc.

Via SBWire

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm ↗

April 11, 2022

Elanco Animal Health Incorporated (NYSE: ELAN) and Ginkgo Bioworks Holdings Inc (NYSE: DNA) have launched BiomEdit, a microbiome innovation company....

Via Benzinga

Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why. ↗

April 07, 2022

Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio.

Via InvestorPlace

Twist Bioscience and Ginkgo Bioworks Sign New Collaboration

April 05, 2022

From Twist Bioscience Corporation

Via Business Wire

36 Stocks Moving In Tuesday's Mid-Day Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Here's Why Ginkgo Bioworks Shares Are Rising ↗

March 29, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 22.0% at $4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above...

Via Benzinga

Is DNA Stock a Buy After Earnings? 3 Analysts Weigh In on Gingko Bioworks. ↗

March 29, 2022

DNA stock is bouncing higher following a better-than-expected earnings report and strong forward guidance from Gingko Bioworks.

Via InvestorPlace

8 Materials Stocks Moving In Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers Ginkgo Bioworks Holdings (NYSE:DNA) shares rose 9.9% to $4.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.8 billion. The company's, Q4 earnings...

Via Benzinga

Why Ginkgo Bioworks Stock Is Rising After Hours ↗

March 28, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher in Monday's after-hours session after the company reported financial results and issued guidance above estimates.

Via Benzinga

Earnings Scheduled For March 28, 2022 ↗

March 28, 2022

Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.

Via Benzinga

Ginkgo Bioworks Adds Ultra-High-Throughput Screening Platform Via FGen Acquisition ↗

March 14, 2022

Ginkgo Bioworks Holdings Inc (NYSE: DNA) has agreed to acquire FGen AG, a Swiss company specializing in strain development and optimization. Under the...

Via Benzinga

23 Stocks That Have Sold Off Hard Since The Russia-Ukraine War Began ↗

March 11, 2022

The S&P 500 is having a rough start to 2022, down 11.27% year to date. Since Russia invaded Ukraine on Feb. 24, the S&P 500 has fallen an additional 0.78%. Following are...

Via Benzinga

7 Stocks to Buy After Sentiment Slipped to Lows ↗

February 17, 2022

With sentiment souring over inflation and other concerns, contrarians may have an opportunity to bank on certain stocks to buy like these.

Via InvestorPlace

Did Going Public Give This Company Momentum? Stran & Company Closes First Acquisition; Adds Over $7 Million in Annualized Revenue ↗

February 03, 2022

Photo by Catkin on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Some...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022 ↗

March 02, 2022

Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth...

Via Benzinga

Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed ↗

January 19, 2022

Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond BOSTON, Jan. 19,...

Via Benzinga

Final Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

January 18, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DNA; SRNG Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors With Losses Exceeding $200K of Class Action

January 18, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Deadline Tomorrow Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

January 17, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.